zarsheedkhan|Latest Current Affairs & World News

are a group of rodent-borne, single-stranded RNA viruses belonging to the Hantaviridae family. Unlike many other vector-borne zoonotic viruses, they are not transmitted by insects (like mosquitoes or ticks) but are carried almost exclusively by wild rodents. While the virus causes a chronic, asymptomatic infection in its host rodents, it can cause severe, life-threatening illnesses when transmitted to humans.
Depending on the geographic region and the specific viral strain, hantaviruses manifest as one of two major clinical syndromes:

1. Hantavirus Pulmonary Syndrome (HPS) / Hantavirus Cardiopulmonary Syndrome (HCPS) – Primarily in the Americas.
2. Hemorrhagic Fever with Renal Syndrome (HFRS) – Primarily in Europe and Asia.

1. Transmission and Risk Factor

• Inhalation (Aerosolization): This is the most common route. When rodent urine, droppings, or saliva dry, the viral particles can become airborne. Sweeping, dusting, or disturbing these materials causes humans to inhale the microscopic virus particles.
• Direct Contact: Touching contaminated surfaces or nesting material and then touching the mouth, nose, or eyes.
• Ingestion: Consuming food or water contaminated by rodent excreta.
• Bites: Though rare, a bite or scratch from an infected rodent can transmit the virus.

Human-to-Human Transmission

For almost all hantaviruses, transmission ends with the infected human (dead-end host). However, there is one notable exception: Andes virus (found in South America). This specific strain is capable of limited human-to-human transmission through close, prolonged contact (such as among household members or intimate partners).

High-Risk Environments

• Cleaning out long-abandoned buildings, barns, cabins, attics, or crawl spaces.
• Agricultural work, forestry, construction, or utility work in rural settings.
• Camping or hiking in areas with active rodent populations.

2. Clinical Syndromes & Symptoms

The incubation period typically ranges from 1 to 8 weeks after exposure.

A. Hantavirus Pulmonary Syndrome (HPS)

Endemic to North and South America (commonly caused by the Sin Nombre virus carried by deer mice, or the Andes virus). It progresses rapidly through distinct phases:

• Prodromal (Early) Phase (Days 1–5): Non-specific flu-like symptoms including high fever, severe muscle aches (especially in the thighs, back, and shoulders), headaches, chills, dizziness, and gastrointestinal issues (nausea, vomiting, diarrhea, abdominal pain).
• Cardiopulmonary Phase: Characterized by a sudden onset of shortness of breath and a persistent cough as the virus attacks the endothelial cells lining the pulmonary capillaries. This causes the capillaries to leak fluid into the lungs (noncardiogenic pulmonary edema), leading to severe respiratory failure, low blood pressure (hypotension), irregular heart rates, and cardiovascular collapse.
• Prognosis: HPS is highly lethal, carrying a mortality rate of 30% to 50%.

B. Hemorrhagic Fever with Renal Syndrome (HFRS)

Endemic to Europe and Asia (commonly caused by Hantaan, Dobrava, or Puumala viruses). It typically progresses through 5 classic clinical phases:

1. Febrile Phase (1–7 days): Abrupt onset of fever, chills, severe headache, lower back pain, abdominal pain, and injection of the conjunctiva.
2. Hypotensive Phase (1–3 days): Blood pressure drops significantly. Thrombocytopenia (low platelets) develops, leading to bleeding manifestations like petechiae (spots on the skin), nosebleeds, or internal bleeding. Shock occurs in severe cases.
3. Oliguric Phase (3–6 days): Kidney function drops precipitously, resulting in low urine output (oliguria), severe hypertension, and acute kidney injury (AKI).
4. Polyuric Phase (Days to weeks): As kidneys begin to recover, urine output spikes drastically (polyuria), which requires careful management of fluid and electrolyte balances.
5. Convalescent Phase (Months): A slow recovery period marked by lingering weakness and fatigue.

• Prognosis: The mortality rate varies significantly depending on the strain—ranging from less than 1% (milder forms like Puumala virus) up to 15% (severe forms like Hantaan virus).

3. Diagnosis

Diagnosing hantavirus early can be challenging because the initial symptoms mimic influenza or other common febrile illnesses.

• Laboratory Testing:
• Serology: Detection of hantavirus-specific IgM and IgG antibodies via ELISA is the standard diagnostic route.
• RT-PCR: Reverse transcriptase-polymerase chain reaction is used to detect viral RNA in the early stages of infection.
• Supportive Lab Findings: Early complete blood counts (CBC) often reveal marked thrombocytopenia (low platelets), leukocytosis (elevated white blood cells), and an elevated hematocrit (due to fluid leaking from blood vessels). Urinalysis in HFRS patients typically demonstrates massive proteinuria and microhematuria.
• Imaging: Chest X-rays in HPS patients will show bilateral infiltrates, increased vascular markings, and pleural effusions reflecting fluid accumulation.

4. Treatment and Management

There is currently no specific antiviral cure or vaccine approved globally for hantavirus infections. Treatment is entirely supportive and relies on intensive medical care.

• Early ICU Admission: Patients suspected of having hantavirus should be transferred immediately to an Intensive Care Unit (ICU).
• Respiratory and Hemodynamic Support:
• Mechanical ventilation and supplemental oxygen are critical for managing respiratory failure.
• Careful fluid monitoring and vasopressors are used to manage hypotension and shock without worsening pulmonary edema.
• Advanced Intervention (ECMO): For severe cases of HPS where the heart and lungs begin to fail completely, initiating Extracorporeal Membrane Oxygenation (ECMO) at the earliest sign of collapse has been shown to significantly increase survival rates.
• Renal Management: For HFRS patients experiencing acute renal failure, temporary hemodialysis is often necessary to manage uremia and fluid overload during the oliguric phase.

5. Prevention and Control

Since treatment options are limited, environmental control and minimizing contact with rodents remain the most effective defenses against the virus.

• Rodent-Proofing Homes: Seal gaps, holes, and cracks in structures where mice or rats can enter. Keep food and pet trash securely sealed.
• Safe Cleanup Protocols:
• Do not sweep or vacuum dry rodent droppings or nests, as this stirs up infectious aerosols.
• Thoroughly spray the affected area with a disinfectant or a mixture of bleach and water (a 1:10 dilution is standard) and let it soak for 5 minutes to inactivate the virus.
• Wear rubber or latex gloves, and use a paper towel to wipe up the materials.
• In highly confined, heavily infested, or poorly ventilated spaces, wearing a well-fitted N95 respirator is strongly advised to avoid inhaling contaminated particles.

Please share your previous comments regarding HANTA VIRUS

zarsheedkhan22@gmail.com